Armata Pharmaceuticals, Inc. (ARMP)Healthcare | Biotechnology | Los Angeles, United States | NYSE American
11.50 USD
+0.12
(1.054%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 11.73 +0.23 (2.000%) ⇧ (April 17, 2026, 6:49 p.m. EDT) Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 4:16 p.m. EDT
ARMP is a high-risk, high-reward stock with a volatile price history and negative fundamentals. The recent news highlights potential breakthroughs in clinical trials, which could drive short-term momentum, but the company's financials are weak, with negative earnings and a low market cap. The lack of dividends and the high short ratio suggest caution. While the options activity hints at some bullish sentiment, the overall picture is not favorable for long-term investment. Short-term traders might consider the recent price fluctuations and potential catalysts, but the risk of a further decline remains significant. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.407091 |
| AutoETS | 0.412662 |
| AutoTheta | 0.413317 |
| AutoARIMA | 0.436502 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 51% |
| H-stat | 3.63 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.279 |
| Excess Kurtosis | -1.06 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 0.135 |
| Market Cap | 421,276,928 |
| Forward P/E | -7.32 |
| Beta | 1.40 |
| Previous Name | Armata Pharmaceuticals Inc. |
| Website | https://www.armatapharma.com |
As of April 11, 2026, 4:16 p.m. EDT: The options data suggests a mixed sentiment. For calls, there is a notable increase in open interest (OI) for out-of-the-money (OTM) strikes, particularly for the May 15 expiration, indicating potential bullish sentiment. However, the low implied volatility (IV) and limited volume suggest uncertainty. On the puts side, there is a significant OI for OTM strikes, especially for the August 21 expiration, which could indicate caution or hedging. The presence of ATM anchors for both calls and puts indicates a focus on the current price level, but the overall activity does not strongly signal a clear direction.
| Attribute | Value |
|---|---|
| 52 Week Change | 8.17742 |
| Address1 | 5,005 McConnell Avenue |
| All Time High | 1,960,000.0 |
| All Time Low | 0.83 |
| Ask | 12.35 |
| Ask Size | 400 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 56,070 |
| Average Daily Volume3 Month | 44,183 |
| Average Volume | 44,183 |
| Average Volume10Days | 56,070 |
| Beta | 1.395 |
| Bid | 10.65 |
| Bid Size | 200 |
| Book Value | -6.0 |
| City | Los Angeles |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 11.5 |
| Current Ratio | 1.192 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 11.77 |
| Day Low | 11.22 |
| Display Name | Armata Pharmaceuticals |
| Dividend Date | 1,557,446,400 |
| Earnings Timestamp | 1,774,468,800 |
| Earnings Timestamp End | 1,778,702,400 |
| Earnings Timestamp Start | 1,778,702,400 |
| Ebitda | -29,691,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -23.597 |
| Enterprise To Revenue | 142.864 |
| Enterprise Value | 700,606,912 |
| Eps Forward | -1.57 |
| Eps Trailing Twelve Months | -4.8 |
| Esg Populated | 0 |
| Exchange | ASE |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 310 665 2963 |
| Fifty Day Average | 9.9078 |
| Fifty Day Average Change | 1.5922003 |
| Fifty Day Average Change Percent | 0.1607017 |
| Fifty Two Week Change Percent | 817.74194 |
| Fifty Two Week High | 16.34 |
| Fifty Two Week High Change | -4.84 |
| Fifty Two Week High Change Percent | -0.29620564 |
| Fifty Two Week Low | 1.17 |
| Fifty Two Week Low Change | 10.33 |
| Fifty Two Week Low Change Percent | 8.829061 |
| Fifty Two Week Range | 1.17 - 16.34 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 769,440,600,000 |
| Float Shares | 11,273,004 |
| Forward Eps | -1.57 |
| Forward P E | -7.3248405 |
| Free Cashflow | -26,727,500 |
| Full Exchange Name | NYSE American |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | -2.20493 |
| Gross Profits | -10,813,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.68674004 |
| Held Percent Institutions | 0.03391 |
| Implied Shares Outstanding | 36,632,775 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ir Website | http://ir.ampliphibio.com/phoenix.zhtml?c=84981&p=irol-stockquote |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,557,446,400 |
| Last Split Factor | 1:14 |
| Long Business Summary | Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc. |
| Long Name | Armata Pharmaceuticals, Inc. |
| Market | us_market |
| Market Cap | 421,276,928 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_84546611 |
| Most Recent Quarter | 1,767,139,200 |
| Name Change Date | 2,026-04-16 |
| Net Income To Common | -173,799,008 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 421,276,912 |
| Number Of Analyst Opinions | 2 |
| Open | 11.38 |
| Operating Cashflow | -25,763,000 |
| Operating Margins | -7.7520695 |
| Payout Ratio | 0.0 |
| Phone | 310 665 2928 |
| Post Market Change | 0.22999954 |
| Post Market Change Percent | 1.9999961 |
| Post Market Price | 11.73 |
| Post Market Time | 1,776,466,157 |
| Prev Name | Armata Pharmaceuticals Inc. |
| Previous Close | 11.38 |
| Price Hint | 2 |
| Price To Book | -1.9166666 |
| Price To Sales Trailing12 Months | 85.904755 |
| Profit Margins | 0.0 |
| Quick Ratio | 1.024 |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | 0.12 |
| Regular Market Change Percent | 1.05448 |
| Regular Market Day High | 11.77 |
| Regular Market Day Low | 11.22 |
| Regular Market Day Range | 11.22 - 11.77 |
| Regular Market Open | 11.38 |
| Regular Market Previous Close | 11.38 |
| Regular Market Price | 11.5 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 35,270 |
| Return On Assets | -0.23896 |
| Revenue Growth | -0.121 |
| Revenue Per Share | 0.135 |
| Sand P52 Week Change | 0.36506534 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 36,632,775 |
| Shares Percent Shares Out | 0.0081 |
| Shares Short | 297,898 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 298,102 |
| Short Name | Armata Pharmaceuticals, Inc. |
| Short Percent Of Float | 0.027 |
| Short Ratio | 9.69 |
| Source Interval | 15 |
| State | CA |
| Symbol | ARMP |
| Target High Price | 20.0 |
| Target Low Price | 15.0 |
| Target Mean Price | 17.5 |
| Target Median Price | 17.5 |
| Total Cash | 8,688,000 |
| Total Cash Per Share | 0.237 |
| Total Debt | 288,017,984 |
| Total Revenue | 4,904,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -4.8 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 5.77825 |
| Two Hundred Day Average Change | 5.72175 |
| Two Hundred Day Average Change Percent | 0.99022186 |
| Type Disp | Equity |
| Volume | 35,270 |
| Website | https://www.armatapharma.com |
| Zip | 90,066 |